rs104894285
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000448.3(RAG1):c.1681C>T(p.Arg561Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R561H) has been classified as Pathogenic.
Frequency
Consequence
NM_000448.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAG1 | NM_000448.3 | c.1681C>T | p.Arg561Cys | missense_variant | 2/2 | ENST00000299440.6 | NP_000439.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250886Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135572
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461878Hom.: 0 Cov.: 36 AF XY: 0.0000138 AC XY: 10AN XY: 727240
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152088Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
Severe combined immunodeficiency, B cell-negative Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2001 | - - |
Severe combined immunodeficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 01, 2024 | Variant summary: RAG1 c.1681C>T (p.Arg561Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 250886 control chromosomes (gnomAD). c.1681C>T has been reported in the literature in multiple individuals affected with Severe Combined Immunodeficiency Syndrome/Omenn Syndrome (e.g. Villa_1998, Villa_2001, Haq_2007, Luk_2017, Cifaldi_2019, Sharapova_2020). These data indicate that the variant is very likely to be associated with disease. A different variant affecting the same codon has been classified as pathogenic by our lab (c.1682G>A, p.Arg561His), supporting the critical relevance of codon 561 to RAG1 protein function. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in <10% of normal activity (Sharapova_2020). The following publications have been ascertained in the context of this evaluation (PMID: 9630231, 11133745, 17572155, 28747913, 31031743, 32655540). ClinVar contains an entry for this variant (Variation ID: 13148). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Histiocytic medullary reticulosis Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2001 | - - |
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 561 of the RAG1 protein (p.Arg561Cys). This variant is present in population databases (rs104894285, gnomAD 0.004%). This missense change has been observed in individuals with severe combined immunodeficiency (SCID) or Omenn Syndrome (PMID: 9630231, 11133745, 26596586; Invitae). ClinVar contains an entry for this variant (Variation ID: 13148). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RAG1 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg561 amino acid residue in RAG1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9630231, 16211094, 24290284, 28783691). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2020 | - - |
Combined immunodeficiency due to partial RAG1 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 10, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at